Mr. Simon Cheng reports

BIOCURE TECHNOLOGY INC. ANNOUNCES ADOPTION OF SEMI-ANNUAL REPORTING

Biocure Technology Inc. has adopted semi-annual financial reporting. This news release is being filed pursuant to Coordinated Blanket Order 51 -- 933 Exemptions to Permit Semi-Annual Reporting for Certain Venture Issuers (CBO 51-933).

CBO 51-933 allows eligible venture issuers to voluntarily move from a quarterly to a semi-annual financial reporting framework. Biocure's fiscal year ends on Dec. 31. Under the provisions of CBO 51-933, Biocure will be exempt from the requirements to file its three-month interim financial statements and associated management's discussion and analysis (MD&A) as it meets the eligibility criteria under CBO 51-933, which include being a venture issuer with annual revenues of less than $10-million and maintaining a clean 12-month continuous disclosure record. Accordingly, Biocure will not be filing its interim financial statements for the three-month period ending March 31, 2026, and associated MD&A (management's discussion and analysis).

Biocure will continue to file audited annual financial statements (due within 120 days of Dec. 31, 2026) and six-month interim financial reports (due within 60 days of June 30, 2026). Biocure remains committed to timely disclosure and will continue to report all material changes and significant developments as required under National Instrument 51-102 -- Continuous Disclosure Obligations .

About Biocure Technology Inc.

Biocure Technology is a Canadian mineral exploration company engaged in the acquisition, exploration and development of mineral properties. The company is focused on advancing its exploration projects and evaluating additional resource opportunities.

We seek Safe Harbor.